More efficient mouse model generation through informed founder selection
Drug Discovery World
JULY 10, 2023
Yet when seeking to obtain an existing model, researchers often encounter obstacles related to intellectual property, availability, or licensing. For projects that utilise gene targeting in ESCs, founders are chimeric (composed of genetically distinct cells derived from two different sources: modified ESCs and a host blastocyst).
52 
Let's personalize your content